Product Images Venlafaxine Hydrochloride

This is a prescription medication called Venlafaxine HCI, which is taken orally as an extended-release 75mg capsule. The medication comes in a package of 30 capsules with an NDC number of 70518-0558-00 and lot number and expiration date listed. The medication is manufactured by Zydus Pharm in Pennington, NJ. The package insert should be referred to for usage instructions, and it should be stored at a temperature between 20-25°C (58-77°F), with exceptions up to 15-30°C (59-86°F), while keeping it out of reach of children. The medication has been repackaged by RemedyRepack Inc. located in Indiana, PA.*

This text appears to be a list of interacting drugs and their corresponding analyte PKFold Change and 90% CRecommendation. The drugs listed include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, and lithium. For each drug, the Cmax and AUC values are provided, along with any relevant recommendations for dose adjustment or use with caution. There is also a footnote referencing a change relative to the reference value.*

This is a report on the recommended dose adjustment for the drug venlafaxine in patients with certain conditions or characteristics that may affect its metabolism or elimination. These include hepatic impairment (cirrhosis or mild/moderate), renal impairment (mild/moderate with hemodialysis), CYP2D8 polymorphism, age (> 80 years), and gender (females/males). The report provides fold-change and 90% confidence interval values for Cmax and AUC for venlafaxine, and recommends dose reductions ranging from 25% to 50% for certain patient groups. Individualization of dosing may also be necessary.*

The text contains the names "eHCI", "H4C0 C", and "venlafaxine hydrochloride". No context is given to evaluate the usefulness of these pieces of information.*